differentiate between colon cancer VS breast cancer
Reading File
Finding Sources
Finding Sources
Searching PubMed
"Colorectal Neoplasms"[MeSH Terms] AND "Breast Neoplasms"[MeSH Terms]
Searching the Web
NCI breast cancer colorectal cancer symptoms screening treatment official
Finding Sources
Finding Sources
Searching the Web
site:cancer.gov/types/breast breast cancer treatment patient symptoms screening
Colon cancer vs breast cancer
| Feature | Colon cancer | Breast cancer |
|---|---|---|
| Where it begins | Inner lining of the large intestine, most often the colon or rectum. | Breast tissue, usually milk ducts or lobules. |
| Common precursor | Often develops gradually from an adenomatous polyp, which can frequently be detected and removed during colonoscopy. | May arise from in-situ disease, such as ductal carcinoma in situ (DCIS), but there is no equivalent routine procedure that removes precursors as directly as colonoscopy does for polyps. |
| Usual histology | Most are adenocarcinomas. | Most are invasive carcinomas of no special type, previously called invasive ductal carcinoma; invasive lobular carcinoma is another common subtype. |
| Typical symptoms | Rectal bleeding or blood in stool, persistent bowel-habit change, abdominal pain, unexplained iron-deficiency anemia, fatigue, weight loss. Right-sided cancers may present mainly with anemia; left-sided cancers more often cause altered bowel habits or obstruction. | New breast or underarm lump, change in breast size/shape, skin dimpling or redness, nipple inversion, nipple discharge, or persistent focal breast change. Early disease often has no symptoms. |
| How it is screened | Stool tests such as FIT, stool DNA-based tests, and colonoscopy. Colonoscopy can detect and remove polyps in the same procedure. Many guidelines begin average-risk screening at age 45. | Mammography is the main screening test. In the US, the USPSTF recommends mammography every 2 years from ages 40 to 74 for average-risk women; some organizations use different intervals or individualized plans. |
| How diagnosis is confirmed | Colonoscopy with biopsy. CT is commonly used for staging. | Diagnostic mammography and/or ultrasound, followed by core needle biopsy. Breast MRI is used selectively. |
| Important biomarkers/genetics | Tumor testing commonly includes mismatch-repair proteins or microsatellite instability (dMMR/MSI), plus RAS and BRAF status in advanced disease. Inherited syndromes include Lynch syndrome and familial adenomatous polyposis. | ER, PR, and HER2 status guide therapy. Germline testing may involve BRCA1, BRCA2, PALB2, and other genes when personal or family history suggests inherited risk. |
| Main spread pattern | Often spreads first to regional lymph nodes and then the liver through portal circulation; can also spread to lung and peritoneum. | Often spreads to axillary/internal mammary nodes and can spread to bone, liver, lung, or brain. |
| Main local treatment | Surgical removal of the involved bowel segment and regional lymph nodes. Rectal cancer often also needs radiation and chemotherapy before or after surgery. | Breast-conserving surgery plus radiation, or mastectomy. Sentinel-node biopsy or axillary surgery may be required. |
| Systemic treatment | Chemotherapy is commonly fluoropyrimidine-based, often with oxaliplatin or irinotecan. Advanced disease may receive biologic targeted therapy or immunotherapy in selected biomarker-defined tumors. | Treatment may include endocrine therapy for ER/PR-positive cancer, HER2-targeted therapy for HER2-positive disease, chemotherapy, immunotherapy for selected subtypes, and other targeted drugs. |
| Major risk factors | Increasing age, family history/inherited syndromes, prior polyps or inflammatory bowel disease, obesity, inactivity, smoking, alcohol, and diets high in processed/red meat. | Increasing age, female sex, family history/inherited variants, longer lifetime estrogen exposure, alcohol, obesity after menopause, prior chest radiation, and some reproductive factors. Men can also develop breast cancer. |
Key practical difference
Colorectal screening can prevent some cancers because it can find and remove polyps before they become malignant. Breast screening primarily aims to find an existing cancer earlier, when treatment is more likely to succeed. The NCI colorectal screening information describes the available tests, while the NCI breast screening overview explains mammographic screening.
When to seek medical assessment
- Possible colon cancer symptoms: visible rectal bleeding, black/tarry stool, persistent new change in bowel habit, unexplained iron-deficiency anemia, unexplained weight loss, or persistent abdominal pain.
- Possible breast cancer symptoms: a new lump, skin dimpling, nipple inversion, bloody nipple discharge, persistent rash/change around the nipple, or a new underarm lump.
These symptoms are often caused by noncancerous conditions, but they should not be ignored. Diagnosis requires clinician assessment and tissue biopsy, not symptoms or screening alone.
For pathology context, invasive breast carcinoma of no special type accounts for roughly 75% of invasive breast cancers, while colorectal cancers are predominantly adenocarcinomas. Robbins, Cotran & Kumar Pathologic Basis of Disease, invasive breast carcinoma section.
This is a shared conversation. Sign in to Orris to start your own chat.